Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)Angelo Famà, James R. Cerhan, Peter Martin et al.|Blood|2019Cited by 13
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United StatesChristopher R. Flowers, James R. Cerhan, Brian K. Link et al.|Blood|2018Cited by 9
Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP studyAndrew L. Feldman, Weina Chen, Kai Fu et al.|Blood|2025Cited by 6
Gene Expression Profiling Reveals Two Overarching Types of Anaplastic Large Cell Lymphoma with Distinct Targetable Biology: An L.L.M.P.P. StudyAndrew L. Feldman, Stephen M. Ansell, Surendra Dasari et al.|Blood|2023Cited by 3
The Fusion Landscape of Anaplastic Large Cell Lymphoma: An L.L.M.P.P. StudyAndrew L. Feldman, Perry M. Anamarija, Guangzhen Hu et al.|Blood|2024Cited by 0